General
Advarra Expands Research Oversight Offerings with Acquisition of Watermark Research Partners
After adding DMC & EAC offerings, Advarra is now the largest integrated independent research oversight services organization
Holiday Meeting Schedule – Canada Day (Canada)
Advarra’s Canadian offices will be closed on Thursday, July 1.
Advarra Announces Key Growth Milestone for The Gene Therapy Ready Network, Becoming Largest IBC Service
Advarra's network has grown to over 500 registered research sites, becomes the largest administrator of institutional biosafety committees
Making the Most of Site Training: Lessons from the Pandemic
Ensure that your next remote site initiation visit is both productive and useful despite the virtual setting with these tips
Advarra Announces Appointment of Jeff Sidell as Chief Technology Officer
Appointment reinforces commitment to innovative, integrated technology solutions to advance clinical research.
What Is an Institutional Biosafety Committee?
An institutional biosafety committee (IBC) ensures research is conducted safely and in compliance with the NIH guidelines. Watch our video to learn the role of an IBC.
BBK Worldwide Features Advarra Executive Michele Russell-Einhorn in Diversity and Inclusion Video
This video discusses methods IRBs can implement to increase diversity and inclusion among trial participants.
Advarra Draws Record Attendance to Onsemble Conference
More than 1,500 attendees are expected at the premier clinical research technology event spanning over four days
Advarra Publishes the State of Clinical Trial Activation at Sites Report
Advarra has published a report providing actionable solutions to streamline study activation and maximize operational efficiency
Cheryl Byers and Dr. John H. Stewart Discuss Diversity, Equity and Inclusion in Cancer Research
Diversity, equity, and inclusion (DEI) in cancer research are critical to clinical research. In this episode, Advarra’s Cheryl Byers and Dr. John H. Stewart have a discussion on what is DEI, the current climate of DEI in cancer research, and considerations to improve DEI in clinical trial enrollment and retention.
The State of Clinical Trial Activation at Sites Report
View our report on actions to streamline study activaiton and maximize operational efficiency.
Advarra Announces Release of Insights Accrual Prediction Platform, A Next-Generation Accrual Prediction Solution For Clinical Trials
Insights Accrual Prediction platform leverages machine learning to accurately predict protocol accrual, strengthening clinical research success.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.